Market revenue in 2023 | USD 309.7 million |
Market revenue in 2030 | USD 447.2 million |
Growth rate | 5.4% (CAGR from 2023 to 2030) |
Largest segment | Clinical |
Fastest growing segment | Pre-Clinical |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Drug Discovery, Pre-Clinical, Clinical |
Key market players worldwide | Icon PLC, Charles River Laboratories International Inc, IQVIA Holdings Inc, GVK Biosciences, Labcorp Holdings Inc, Thermo Fisher Scientific Inc, PAREXEL, Dassault Systemes SE, Pharmaron Beijing Co Ltd Ordinary Shares - Class H, SGS AG, Worldwide Clinical Trials, Wuxi AppTec Co Ltd, Caidya |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to healthcare contract research organization market will help companies and investors design strategic landscapes.
Clinical was the largest segment with a revenue share of 74.14% in 2023. Horizon Databook has segmented the Canada healthcare contract research organization market based on drug discovery, pre-clinical, clinical covering the revenue growth of each sub-segment from 2018 to 2030.
The government’s large investments and the numerous contracts that international companies receive are expected to propel the CRO market growth in Canada. The R&D tax credit in Canada makes outsourcing a viable choice.
Taxpayers in Canada are permitted to claim 15% of the federal tax credit that is not refundable. Furthermore, funding is available to a CRO even in cases where the sponsor is a foreign client.
In order to gain a competitive edge, Canadian CROs are expanding their presence in developing regions, such as South & Central America. Companies in Canada are providing infrastructure to Canadian researchers for various types of clinical research.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada healthcare contract research organization market , including forecasts for subscribers. This country databook contains high-level insights into Canada healthcare contract research organization market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account